Article Text

Download PDFPDF
Venous thromboembolism complications in shoulder surgery: current concepts
  1. Michael R. Mancini,
  2. Matthew R. LeVasseur,
  3. Benjamin C. Hawthorne,
  4. Daniel E. Marrero,
  5. Augustus D. Mazzocca
  1. Department of Orthopaedic Surgery, University of Connecticut Health Center, Farmington, Connecticut, USA
  1. Correspondence to Michael R. Mancini, Orthopaedic Surgery, University of Connecticut Health Center, Farmington, CT 06030, USA; mancini.michaelr{at}gmail.com

Abstract

Venous thromboembolism (VTE) is a rare yet known complication of shoulder surgery. Concerning shoulder arthroplasty, reported rates of VTE range from 0.2% to 16%. Unlike many lower extremity procedures, particularly total hip and knee arthroplasty, chemical prophylactic guidelines for VTE in shoulder surgeries have not been established. Some argue that doing so is unnecessary. On the contrary, mechanical prophylaxis is nearly universally accepted in shoulder surgery, particularly for more lengthy procedures. With limited VTE incidence in shoulder surgery, treatment is anecdotally derived from the hip and knee arthroplasty literature. Recent studies have successfully identified risk factors for VTE related to the patient and to the surgery itself. Awareness of these risk factors by the surgeon and declaration of these factors to the patient should be discussed as part of the informed consent process. Further investigational studies and larger patient cohorts will be necessary to optimise VTE prevention in shoulder surgeries.

  • shoulder
  • orthopaedics
  • reconstructive surgical procedures
  • arthroplasty
  • arthroscopy

Statistics from Altmetric.com

Footnotes

  • Contributors MRM contributed to the conception, drafting, revising and final approval of the manuscript. MRL, BCH, DEM and ADM contributed to the conception, revising and final approval of the manuscript. All authors attest to the accuracy and integrity of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Authors MRM, MRL, BCH, DEM and their immediate families do not have any competing interests or disclaimers. ADM has received research support from Arthrex, consulting fees from Arthrex and Astellas Pharma and honoraria from Arthrosurface.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.